Page last updated: 2024-09-03
tak 044 and metoprolol
tak 044 has been researched along with metoprolol in 1 studies
Compound Research Comparison
Studies (tak 044) | Trials (tak 044) | Recent Studies (post-2010) (tak 044) | Studies (metoprolol) | Trials (metoprolol) | Recent Studies (post-2010) (metoprolol) |
---|---|---|---|---|---|
105 | 8 | 2 | 5,821 | 1,743 | 1,304 |
Protein Interaction Comparison
Protein | Taxonomy | tak 044 (IC50) | metoprolol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 2.573 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.176 | |
Cytochrome P450 2C9 | Homo sapiens (human) | 4.87 | |
Cytochrome P450 2J2 | Homo sapiens (human) | 4.87 |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Davenport, AP; Dhaun, N; Ferro, CJ; Goddard, J; Haynes, WG; Webb, DJ | 1 |
Trials
1 trial(s) available for tak 044 and metoprolol
Article | Year |
---|---|
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney disease.
Topics: Adult; Blood Pressure; Cross-Over Studies; Double-Blind Method; Doxazosin; Enalapril; Endothelin Receptor Antagonists; Furosemide; Hemodynamics; Humans; Kidney Failure, Chronic; Male; Metoprolol; Middle Aged; Peptides, Cyclic; Prospective Studies | 2007 |